Drug Database
Back to search

Netherlands· NL-38a25e92e64d

Triamcinolonacetonide Ace 1 mg/g, crème

A triamcinolone product containing triamcinolonacetonide, registered in Netherlands by ACE Pharmaceuticals B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC D07AB09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTriamcinolonacetonide Ace 1 mg/g, crè…ATCD07AB09REGISTER NO.NL-38a25e92e64dPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about triamcinolonacetonideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Triamcinolone is registered in 7 of 19 countries.

Countries holding a registration under ATC D07AB09 (triamcinolone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose
Search triamcinolone products by name

Triamcinolone · ATC D07AB09

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Netherlands
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRIAMCINOLONACETONIDE
Manufacturer
ACE Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
D07AB09
ATC class
Triamcinolone
Defined daily dose
2 mg, T
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    50801

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for triamcinolone.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check triamcinolone against other medicinesHow interaction checks work

Triamcinolone · interactions on record

55 records

  • 55 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Triamcinolone in 16 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All triamcinolone products

    Authorised across Europe · EMA

    The same active substance is authorised in 27 EEA countries. Names it is sold under:

    • Austria · Volon, Volon A
    • Belgium · Delphi, Kenacort-A
    • Cyprus · Triacort
    • Czechia · Triamcinolon Léčiva
    • Germany · Nasacort, Rhinisan
    • Denmark · Kenalog, Triamcinolone Acetonide Medipha
    • Estonia · Kenalog
    • Spain · Nasacort
    • Finland · Nasacort, Triamcinolone Medipha
    • France · Kenacort Retard, Nasacort
    • United Kingdom (Northern Ireland) · Nasacort
    • Greece · Jiven, Nasacort
    • Croatia · Kenalog
    • Hungary · Ftorocort, Kenalog
    • Ireland · Nasacort, Nasacort Allergy
    • Iceland · Kenacort-T, Nasacort
    • Italy · Kenacort, Nasacort
    • Lithuania · Ftorocort, Kenalog
    • Luxembourg · Delphi, Kenacort-A
    • Latvia · Ftorocort, Kenalog
    • Malta · Nasacort, Nasacort Allergy
    • Norway · Kenacort-T, Nasacort
    • Poland · Polcortolon
    • Portugal · Nasacort, Telfast Spray Nasal
    • Sweden · Kenacort-T, Nasacort
    • Slovenia · Kenalog
    • Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/bf40ac29-56b0-4fef-be6b-2b3b5a18b569
GET /v1/drugs/bf40ac29-56b0-4fef-be6b-2b3b5a18b569?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h50801_smpc.pdf",
  "strength": null,
  "atc_label": "Triamcinolone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg50801",
  "excipients": [
    "CETOSTEARYLALCOHOL",
    "DECYLOLEAAT",
    "MACROGOLCETOSTEARYLETHER",
    "RIJSTZETMEEL",
    "SORBINEZUUR (E 200)",
    "SORBITOL (E 420)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "TRIAMCINOLONACETONIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h50801.pdf",
  "authorised_at": "1983/08/29",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "50801",
  "additional_monitoring": "N"
}
    API referenceMCP serverPlans

    See everything about triamcinolone.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console